BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32627036)

  • 1. M2 macrophages reduce the radiosensitivity of head and neck cancer by releasing HB‑EGF.
    Fu E; Liu T; Yu S; Chen X; Song L; Lou H; Ma F; Zhang S; Hussain S; Guo J; Sun J; Yu P; Mao X; Wei L
    Oncol Rep; 2020 Aug; 44(2):698-710. PubMed ID: 32627036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV + HNSCC-derived exosomal miR-9 induces macrophage M1 polarization and increases tumor radiosensitivity.
    Tong F; Mao X; Zhang S; Xie H; Yan B; Wang B; Sun J; Wei L
    Cancer Lett; 2020 May; 478():34-44. PubMed ID: 32120025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6 induced M1 type macrophage polarization increases radiosensitivity in HPV positive head and neck cancer.
    Chen X; Fu E; Lou H; Mao X; Yan B; Tong F; Sun J; Wei L
    Cancer Lett; 2019 Aug; 456():69-79. PubMed ID: 31055110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR overexpression increases radiotherapy response in HPV-positive head and neck cancer through inhibition of DNA damage repair and HPV E6 downregulation.
    Alsahafi EN; Thavaraj S; Sarvestani N; Novoplansky O; Elkabets M; Ayaz B; Tavassoli M; Legends MF
    Cancer Lett; 2021 Feb; 498():80-97. PubMed ID: 33137407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic E6 and/or E7 proteins drive proliferation and invasion of human papilloma virus‑positive head and neck squamous cell cancer through upregulation of Ror2 expression.
    Avincsal MO; Kamizaki K; Jimbo N; Shinomiya H; Nibu KI; Nishita M; Minami Y
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34080643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of CDK4/CDK6 Enhances Radiosensitivity of HPV Negative Head and Neck Squamous Cell Carcinomas.
    Göttgens EL; Bussink J; Leszczynska KB; Peters H; Span PN; Hammond EM
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):548-558. PubMed ID: 31271827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor associated macrophages induce epithelial to mesenchymal transition via the EGFR/ERK1/2 pathway in head and neck squamous cell carcinoma.
    Gao L; Zhang W; Zhong WQ; Liu ZJ; Li HM; Yu ZL; Zhao YF
    Oncol Rep; 2018 Nov; 40(5):2558-2572. PubMed ID: 30132555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma.
    Yang L; Kumar B; Shen C; Zhao S; Blakaj D; Li T; Romito M; Teknos TN; Williams TM
    Mol Cancer Ther; 2019 Jun; 18(6):1025-1035. PubMed ID: 31015310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV, hypoxia and radiation response in head and neck cancer.
    Göttgens EL; Ostheimer C; Span PN; Bussink J; Hammond EM
    Br J Radiol; 2019 Jan; 92(1093):20180047. PubMed ID: 29493265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity.
    Rieckmann T; Tribius S; Grob TJ; Meyer F; Busch CJ; Petersen C; Dikomey E; Kriegs M
    Radiother Oncol; 2013 May; 107(2):242-6. PubMed ID: 23602369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Radiation Sensitivity of Human Papillomavirus-Driven Head and Neck Cancer: Focus on Immunological Aspects.
    Özcan-Wahlbrink M; Schifflers C; Riemer AB
    Front Immunol; 2019; 10():2831. PubMed ID: 31849993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cetuximab-induced natural killer cell cytotoxicity in head and neck squamous cell carcinoma cell lines: investigation of the role of cetuximab sensitivity and HPV status.
    Baysal H; De Pauw I; Zaryouh H; De Waele J; Peeters M; Pauwels P; Vermorken JB; Smits E; Lardon F; Jacobs J; Wouters A
    Br J Cancer; 2020 Sep; 123(5):752-761. PubMed ID: 32541873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus 16 promotes microhomology-mediated end-joining.
    Leeman JE; Li Y; Bell A; Hussain SS; Majumdar R; Rong-Mullins X; Blecua P; Damerla R; Narang H; Ravindran PT; Lee NY; Riaz N; Powell SN; Higginson DS
    Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21573-21579. PubMed ID: 31591214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
    Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
    BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CENPM upregulation by E5 oncoprotein of human papillomavirus promotes radiosensitivity in head and neck squamous cell carcinoma.
    Liu T; Ma L; Song L; Yan B; Zhang S; Wang B; Zuo N; Sun X; Deng Y; Ren Q; Li Y; Zhou J; Liu Q; Wei L
    Oral Oncol; 2022 Jun; 129():105858. PubMed ID: 35462155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosensitization approaches for HPV-positive and HPV-negative head and neck squamous carcinomas.
    Dok R; Bamps M; Glorieux M; Zhao P; Sablina A; Nuyts S
    Int J Cancer; 2020 Feb; 146(4):1075-1085. PubMed ID: 31283004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infiltrates of M2-Like Tumour-Associated Macrophages Are Adverse Prognostic Factor in Patients with Human Papillomavirus-Negative but Not in Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.
    Snietura M; Brewczynski A; Kopec A; Rutkowski T
    Pathobiology; 2020; 87(2):75-86. PubMed ID: 32036360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of B lymphocyte infiltration in HPV
    Zhang S; Wang B; Ma F; Tong F; Yan B; Liu T; Xie H; Song L; Yu S; Wei L
    Cancer Sci; 2021 Apr; 112(4):1402-1416. PubMed ID: 33529452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
    Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
    J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects.
    Wang L; Zhang P; Molkentine DP; Chen C; Molkentine JM; Piao H; Raju U; Zhang J; Valdecanas DR; Tailor RC; Thames HD; Buchholz TA; Chen J; Ma L; Mason KA; Ang KK; Meyn RE; Skinner HD
    Oncogene; 2017 Feb; 36(6):820-828. PubMed ID: 27425591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.